MEROPENEM-VABORBACTAM

MEROPENEM-VABORBACTAM was reported 50 times

MEROPENEM-VABORBACTAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MINIMUM INHIBITORY CONCENTRATION INCREASED 2 0.1000
1 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 1 0.0096
2 PANCREATIC ABSCESS 1 0.0050
3 INFUSION SITE PHLEBITIS 1 0.0044
4 VASCULAR ACCESS SITE COMPLICATION 1 0.0040
5 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
6 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
7 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
8 ABDOMINAL WALL ABSCESS 1 0.0015
9 BACTERIAL DISEASE CARRIER 1 0.0014
10 ALLERGIC COUGH 1 0.0013
11 BLOOD CULTURE POSITIVE 2 0.0007
12 MEDICAL DEVICE PAIN 1 0.0005
13 BRAIN ABSCESS 1 0.0004
14 EXTRAVASATION 1 0.0002
15 PRODUCT CONTAINER ISSUE 2 0.0002
16 ABDOMINAL ABSCESS 1 0.0002
17 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
18 INTESTINAL ISCHAEMIA 1 0.0002
19 PRODUCT LABEL CONFUSION 1 0.0002
20 DRUG DIVERSION 1 0.0002
21 INFUSION SITE EXTRAVASATION 1 0.0002
22 INFUSION SITE SWELLING 1 0.0002
23 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
24 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
25 INFUSION SITE ERYTHEMA 1 0.0001
26 DRUG ERUPTION 2 0.0001
27 FLANK PAIN 1 0.0001
28 STEVENS-JOHNSON SYNDROME 2 0.0001
29 INJECTION SITE IRRITATION 1 0.0001
30 DRUG RESISTANCE 2 0.0001
31 DEVICE RELATED INFECTION 1 0.0001
32 PRODUCT PREPARATION ERROR 1 0.0000
33 HALLUCINATION, VISUAL 1 0.0000
34 LIVER FUNCTION TEST INCREASED 1 0.0000
35 HEPATOTOXICITY 1 0.0000
36 INFLAMMATION 2 0.0000
37 RASH PRURITIC 2 0.0000
38 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
39 EXPIRED PRODUCT ADMINISTERED 1 0.0000
40 HYPOXIA 1 0.0000
41 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
42 OFF LABEL USE 19 0.0000
43 SWELLING 2 0.0000
44 RASH ERYTHEMATOUS 1 0.0000
45 PERIPHERAL SWELLING 3 0.0000
46 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
47 SEIZURE 2 0.0000
48 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
49 HYPERSENSITIVITY 3 0.0000
50 BLOOD CREATININE INCREASED 1 0.0000
51 ERYTHEMA 3 0.0000
52 BURNING SENSATION 1 0.0000
53 MOBILITY DECREASED 1 0.0000
54 RESPIRATORY FAILURE 1 0.0000
55 EPISTAXIS 1 0.0000
56 ACUTE KIDNEY INJURY 2 0.0000
57 TREATMENT FAILURE 1 0.0000
58 CONDITION AGGRAVATED 3 0.0000
59 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
60 DISEASE PROGRESSION 1 0.0000
61 RASH 3 0.0000
62 PAIN IN EXTREMITY 2 0.0000
63 HYPOAESTHESIA 1 0.0000
64 INJECTION SITE PAIN 2 0.0000
65 PARAESTHESIA 1 0.0000
66 CONFUSIONAL STATE 1 0.0000
67 URINARY TRACT INFECTION 1 0.0000
68 DEATH 5 0.0000
69 MYOCARDIAL INFARCTION 1 0.0000
70 PRURITUS 2 0.0000
71 HYPOTENSION 1 0.0000
72 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
73 HEADACHE 2 0.0000
74 PNEUMONIA 1 0.0000
75 PYREXIA 1 0.0000
76 ASTHENIA 1 0.0000
77 DRUG INEFFECTIVE 3 0.0000
78 DIARRHOEA 1 0.0000